Cargando…

The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population‐based sample of people with known and newly detected diabetes in Barbados: a cross‐sectional study

AIMS: To determine the prevalence and potential risk factors for diabetic peripheral neuropathy with a loss of protective sensation in Barbados. METHODS: A representative population sample aged > 25 years with previously diagnosed diabetes or a fasting blood glucose ≥ 7 mmol/l or HbA(1c) ≥ 48 mmo...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, O. P., Herbert, J. R., Howitt, C., Unwin, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900017/
https://www.ncbi.nlm.nih.gov/pubmed/31094005
http://dx.doi.org/10.1111/dme.13989
_version_ 1783477261591117824
author Adams, O. P.
Herbert, J. R.
Howitt, C.
Unwin, N.
author_facet Adams, O. P.
Herbert, J. R.
Howitt, C.
Unwin, N.
author_sort Adams, O. P.
collection PubMed
description AIMS: To determine the prevalence and potential risk factors for diabetic peripheral neuropathy with a loss of protective sensation in Barbados. METHODS: A representative population sample aged > 25 years with previously diagnosed diabetes or a fasting blood glucose ≥ 7 mmol/l or HbA(1c) ≥ 48 mmol/mol (6.5%) was tested by 10 g monofilament at four plantar sites per foot and a 28 Hz tuning fork and neurothesiometer at the hallux. Data were adjusted to the age structure of people with diabetes in Barbados. Multivariable logistic regression assessed associations with peripheral neuropathy with a loss of protective sensation. RESULTS: Of 236 participants [74% response rate, 33% men, 91% black, median age 58.6 years, mean BMI 30.1 kg/m(2), mean HbA(1c) 54 mmol/mol (7.1%)], 51% had previously diagnosed diabetes. Foot examination demonstrated that 25.8% (95% CI 20.2 to 31.5) had at least one insensate site with monofilament testing, 14.8% (95% CI 10.2 to 19.4) had an abnormal tuning fork test and 10.9% (95% CI 6.9 to 14.9) had a vibration perception threshold > 25 V. Peripheral neuropathy with a loss of protective sensation prevalence was 28.5% (95% CI 22.7 to 34.4) as indicated by monofilament with ≥ 1 insensate site and/or vibration perception threshold > 25 V. With previously diagnosed diabetes the prevalence was 36.4% (95% CI 27.7 to 45.2) with 98.4% of cases identified by monofilament testing. Increasing age, previously diagnosed diabetes, male sex and abdominal obesity were independently associated with peripheral neuropathy with a loss of protective sensation. CONCLUSIONS: Over a third of people with previously diagnosed diabetes had evidence of peripheral neuropathy with a loss of protective sensation. Monofilament testing alone may be adequate to rule out peripheral neuropathy with a loss of protective sensation. Monofilament and neurothesiometer stimuli are reproducible but dependent on participant response.
format Online
Article
Text
id pubmed-6900017
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69000172019-12-20 The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population‐based sample of people with known and newly detected diabetes in Barbados: a cross‐sectional study Adams, O. P. Herbert, J. R. Howitt, C. Unwin, N. Diabet Med Research Articles AIMS: To determine the prevalence and potential risk factors for diabetic peripheral neuropathy with a loss of protective sensation in Barbados. METHODS: A representative population sample aged > 25 years with previously diagnosed diabetes or a fasting blood glucose ≥ 7 mmol/l or HbA(1c) ≥ 48 mmol/mol (6.5%) was tested by 10 g monofilament at four plantar sites per foot and a 28 Hz tuning fork and neurothesiometer at the hallux. Data were adjusted to the age structure of people with diabetes in Barbados. Multivariable logistic regression assessed associations with peripheral neuropathy with a loss of protective sensation. RESULTS: Of 236 participants [74% response rate, 33% men, 91% black, median age 58.6 years, mean BMI 30.1 kg/m(2), mean HbA(1c) 54 mmol/mol (7.1%)], 51% had previously diagnosed diabetes. Foot examination demonstrated that 25.8% (95% CI 20.2 to 31.5) had at least one insensate site with monofilament testing, 14.8% (95% CI 10.2 to 19.4) had an abnormal tuning fork test and 10.9% (95% CI 6.9 to 14.9) had a vibration perception threshold > 25 V. Peripheral neuropathy with a loss of protective sensation prevalence was 28.5% (95% CI 22.7 to 34.4) as indicated by monofilament with ≥ 1 insensate site and/or vibration perception threshold > 25 V. With previously diagnosed diabetes the prevalence was 36.4% (95% CI 27.7 to 45.2) with 98.4% of cases identified by monofilament testing. Increasing age, previously diagnosed diabetes, male sex and abdominal obesity were independently associated with peripheral neuropathy with a loss of protective sensation. CONCLUSIONS: Over a third of people with previously diagnosed diabetes had evidence of peripheral neuropathy with a loss of protective sensation. Monofilament testing alone may be adequate to rule out peripheral neuropathy with a loss of protective sensation. Monofilament and neurothesiometer stimuli are reproducible but dependent on participant response. John Wiley and Sons Inc. 2019-06-18 2019-12 /pmc/articles/PMC6900017/ /pubmed/31094005 http://dx.doi.org/10.1111/dme.13989 Text en © 2019 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Adams, O. P.
Herbert, J. R.
Howitt, C.
Unwin, N.
The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population‐based sample of people with known and newly detected diabetes in Barbados: a cross‐sectional study
title The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population‐based sample of people with known and newly detected diabetes in Barbados: a cross‐sectional study
title_full The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population‐based sample of people with known and newly detected diabetes in Barbados: a cross‐sectional study
title_fullStr The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population‐based sample of people with known and newly detected diabetes in Barbados: a cross‐sectional study
title_full_unstemmed The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population‐based sample of people with known and newly detected diabetes in Barbados: a cross‐sectional study
title_short The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population‐based sample of people with known and newly detected diabetes in Barbados: a cross‐sectional study
title_sort prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population‐based sample of people with known and newly detected diabetes in barbados: a cross‐sectional study
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6900017/
https://www.ncbi.nlm.nih.gov/pubmed/31094005
http://dx.doi.org/10.1111/dme.13989
work_keys_str_mv AT adamsop theprevalenceofperipheralneuropathysevereenoughtocausealossofprotectivesensationinapopulationbasedsampleofpeoplewithknownandnewlydetecteddiabetesinbarbadosacrosssectionalstudy
AT herbertjr theprevalenceofperipheralneuropathysevereenoughtocausealossofprotectivesensationinapopulationbasedsampleofpeoplewithknownandnewlydetecteddiabetesinbarbadosacrosssectionalstudy
AT howittc theprevalenceofperipheralneuropathysevereenoughtocausealossofprotectivesensationinapopulationbasedsampleofpeoplewithknownandnewlydetecteddiabetesinbarbadosacrosssectionalstudy
AT unwinn theprevalenceofperipheralneuropathysevereenoughtocausealossofprotectivesensationinapopulationbasedsampleofpeoplewithknownandnewlydetecteddiabetesinbarbadosacrosssectionalstudy
AT adamsop prevalenceofperipheralneuropathysevereenoughtocausealossofprotectivesensationinapopulationbasedsampleofpeoplewithknownandnewlydetecteddiabetesinbarbadosacrosssectionalstudy
AT herbertjr prevalenceofperipheralneuropathysevereenoughtocausealossofprotectivesensationinapopulationbasedsampleofpeoplewithknownandnewlydetecteddiabetesinbarbadosacrosssectionalstudy
AT howittc prevalenceofperipheralneuropathysevereenoughtocausealossofprotectivesensationinapopulationbasedsampleofpeoplewithknownandnewlydetecteddiabetesinbarbadosacrosssectionalstudy
AT unwinn prevalenceofperipheralneuropathysevereenoughtocausealossofprotectivesensationinapopulationbasedsampleofpeoplewithknownandnewlydetecteddiabetesinbarbadosacrosssectionalstudy